Desert Horse-Grant has been named one of the 48 Chief Transformation Officers to Know
Sylvester Comprehensive Cancer Center shared on LinkedIn:
“Chief Transformation Officer Desert Horse-Grant for Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has been named one of the 48 Chief Transformation Officers to Know by Becker’s Hospital Review.
Becker’s Hospital Review’s 2024 edition of the Chief Transformation Officers to Know list highlights the essential role these executives play in driving substantial, long-term change within hospitals and health systems.
This recognition honors Horse-Grant and other transformation officers for their dedication to optimizing health care and guiding their institutions through transformative processes that ensure continued success.
The recognition also highlights Horse-Grant’s pivotal role in leading transformative initiatives within the health-care sector, particularly at the intersection of science, medicine and underrepresented communities.
“It is an honor to be recognized among such innovative leaders in the health care transformation sector. At Sylvester, our mission is to ensure that groundbreaking research and treatment options are accessible to all, especially underrepresented communities. This recognition is a testament to the collective efforts of our team and our commitment to driving meaningful change in cancer care.”
In her role at Sylvester, Horse-Grant is a staunch advocate for the transformation and empowerment of underrepresented minorities in the fields of science and medicine. She spearheads innovation and strategy and focuses on championing the increase of clinical trials across multiple sites in Africa and the Caribbean.
Additionally, she has an executive advisory role in the development of a new $260 million cancer research building, which will effectively double the research footprint of Sylvester Comprehensive Cancer Center.
Before her current role, Horse-Grant served as chief of innovation at UCLA Health, where she was instrumental in facilitating the translation of groundbreaking discoveries from the lab to clinical settings. Her leadership extends to her tenure as a director at Fred Hutch in Seattle, where she led a team in developing a novel biotool for tissue microstructure.
This pioneering work was recognized for its social impact by GitHub and was awarded a publication in Nature Genetics.
Earlier in her career, while at New York City’s Memorial Sloan Kettering Cancer Center, Horse-Grant helped to establish the Physical Sciences-Oncology Center, a groundbreaking initiative that brought together researchers at the intersection of computational medicine and cancer biology.”